SecBot SecBot
COURT-RULING ·Filed May 29, 2026

ALGN

ALIGN TECHNOLOGY INC
BEARISH
Impact 6/10
Horizonmonths Processed5mo ago CourtCourt Ruling · courtlistener.com
Court ruling (district)
Actionable Insight ▼ Bearish

The denial of Align's § 101 challenge means the case survives into discovery and claim construction, creating ongoing litigation overhang for ALGN's iTero scanner revenue stream. However, the dismissal of willful/indirect claims limits damages exposure to post-complaint conduct only. Monitor for claim construction rulings (especially on 'random patterns' and 'memory' terms) and any settlement developments, these are the next key catalysts.

DirectionBearish
Confidencehigh
Horizonmonths

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$169.77
T+0 close · Jun 1, 2026 · via day close
Latest settled
−6.26%
T+60 · $159.14
Vs SPY
−7.52%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 1 $169.77entry
  2. T+1 · 6mo ago −1.81%α −1.95% · $166.69
  3. T+5 · 5mo ago +1.34%α +3.89% · $172.05
  4. T+20 · 5mo ago −0.65%α +0.64% · $168.66
  5. T+60 · 3mo ago −6.26%α −7.52% · $159.14
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The Delaware district court denied Align's motion to dismiss Densys's patent infringement claims on § 101 subject-matter eligibility grounds, ruling that both asserted patents (the '707 and '257 patents) are directed to patent-eligible technological improvements in intra-oral 3D imaging rather than abstract ideas. However, the court granted Align's motion to dismiss for failure to state a claim on direct infringement of the '257 patent (lack of plausible 'memory' element) and dismissed all willful and indirect infringement claims against Align without prejudice for insufficient pleading of knowledge. The case survives on direct infringement of the '707 patent, preserving material litigation exposure for Align's iTero scanner product line.

Court Ruling Details

Ruling Date
May 29, 2026
Court
United States District Court for the District of Delaware
Court Level
District
Judge
Gregory B. Williams
Case Type
patent
Ruling Type
motion to dismiss
Outcome
PARTIAL: mixed ruling, some claims won/lost
Appeal Timeline
1-2 years if interlocutory appeal pursued
Precedent Risk
LOW

Key Facts

  • Court denied Align's motion to dismiss on § 101 patent-eligibility for both the '707 and '257 patents, patents survive as valid.
  • Court granted Align's motion to dismiss direct infringement claim for the '257 patent (no plausible 'memory' element), but without prejudice.
  • All willful and indirect infringement claims against Align dismissed without prejudice for insufficient pleading of knowledge.
  • Direct infringement claim on the '707 patent survives, Align's iTero scanners remain accused of infringing a key intra-oral scanning patent.
  • The ruling is interlocutory (motion to dismiss stage), not a final judgment, case proceeds to discovery and claim construction.
  • Align's iTero scanner product line (iTero Element 5D, iTero Lumina, etc.) is the accused product category.

Financial Impact

No damages awarded or pleaded amount stated in the opinion. Potential exposure from a surviving patent infringement case on a core product line (iTero scanners), material but unquantifiable at this stage.

revenuelegal exposureproduct risk

Risk Factors

  • If Densys prevails on the '707 patent, Align could face an injunction against iTero scanner sales or substantial ongoing royalties.
  • Claim construction on key terms ('random patterns', 'memory') could expand or contract infringement exposure significantly.
  • Parallel case against Medit (dismissed more broadly) may reduce co-defendant leverage but does not directly affect Align.
  • Appeal of § 101 ruling is possible but unlikely to succeed given the court's thorough analysis aligning with Federal Circuit precedent (Thales Visionix, Koninklijke).

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
71% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-rrpst4hh-ALGN

Track record

19 reports on ALGN

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +12.30% at T+60 after the Aug 3, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $168.32 Now $165.98 −1.39% settles Dec 14
  2. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $172.08 Now $165.98 −3.54% settles Dec 10
  3. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $166.00 Now $165.98 −0.01% settles Dec 7
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $159.37 Now $165.98 +4.15% settles Dec 4
  5. Nov 2, 202614d ago 3 Neutral 1/10 Entry $151.58 Now $165.98 +9.50% settles Dec 2
  6. Oct 28, 202619d ago 8-K Neutral 3/10 Entry $153.71 Now $165.98 +7.98% settles Nov 27
  7. Oct 28, 202619d ago 8-K Neutral 5/10 Entry $153.71 Now $165.98 +7.98% settles Nov 27
  8. Oct 21, 202627d ago PTAB Trial Mixed 6/10 Entry $155.51 Now $165.98 +6.73% settles Nov 19
  9. Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $148.90 to $165.98 Now $165.98 −11.47% ▼ −11.47% −14.93% vs SPY
  10. Aug 31, 202611w ago 8-K Neutral 2/10 Entry $154.96 to $145.35 Now $165.98 +7.11% ▼ −6.20% −6.52% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens Wed (11h 45m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published May 31, 2026